No Picture
San Diego Biotech Jobs

Research Associate

Operations Coordinator (Research Associate) Celgene – San Diego, CA 12 months with a possibility of extension Job Description: This is a full time (40 hours/week) contractor position. We are looking for an operations coordinator who has a can-do attitude […]

No Picture
San Diego Biotech Jobs

Inside Sales

Job Description: * Describe the Benefits of the medical device, Determine Need and Fit * Determines Financial Feasibility for Patient * Serve as Primary Point of Contact for NEW Patients, works with Patient Account Specialist to ensure all requirements me […]

No Picture
PR Newswire

Rigel Pharmaceuticals, Inc. Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Dec. 8, 2017 /PRNewswire/ — Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that on December 4, 2017 the Compensation Committee of Rigel’s Board of Directors approved the grant of inducement stock options to purcha… […]

No Picture
San Diego Biotech Jobs

Senior BioProcess Engineer/Scientist

Overview: The Senior BioProcess Engineer is responsible for organizing, running, sustaining, and continuously improving the manufacturing operations process at the plant/site. This individual will work on the manufacturing floor to produce product, troubl […]

No Picture
PR Newswire

Biotheranostics, Inc. Announces Several Data Disclosures at the 40th annual San Antonio Breast Cancer Symposium

Findings from correlative studies elucidate association between Breast Cancer IndexSM (BCI) with traditional clinicopathologic and molecular factors

SAN DIEGO, Dec. 8, 2017 /PRNewswire/ — Biotheranostics releases the results from 6 multi-institution… […]

No Picture
News

Using ACEA’s xCELLigence RTCA, Oxford Scientists Show Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types

SAN DIEGO–(BUSINESS WIRE)–In a research article published in EMBO Molecular Medicine, a group of scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single … […]

No Picture
PR Newswire

Rigel to Present One-Year Efficacy and Safety Results for Fostamatinib in ITP at the 2017 American Society of Hematology Annual Meeting

SOUTH SAN FRANCISCO, Calif., Dec. 8, 2017 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the one-year efficacy and safety results from its FIT Phase 3 clinical program of fostamatinib for chronic or persistent immune … […]